| l Institutes of Health NCI. “Cannabis and Cannabinoids (PDQ®)–Patient Version.”Dec 20, 2017. |
| Dialogues Clin Neurosci. 2007 Dec; 9(4): 413–430. |
| CW Journal. “Hemp & Flax in Colonial America.” Winter 2015. |
| CBS News. November 17, 2016. |
| Newsweek. December 17, 2015. |
| www.ncbi.nlm.nih.gov/search/all/?term=mechoulam |
| Gen Pharmacol. 1994 Jan;25(1):161-4. |
| Arthritis Rheum. 2004 Mar;50(3):985-98. |
| Br J Clin Pharmacol. 2013 Feb;75(2):323-33. |
| Handb Exp Pharmacol. 2011;(203):75-104. |
| Trends Pharmacol Sci. 2009 Oct;30(10):515-27. |
| J Bone Miner Res. 2015 Oct;30(10):1905-13. |
| Mol Pharmacol. 1988 Nov;34(5):605-13. |
| Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8257-62. |
| National Institutes of Health. FEBS J. 2013 May; 280(9): 1918–1943. |
| Neuropharmacology. 2016 Apr;103:16-26. |
| Neuropsychopharmacology. 2011;36, 1219–1226. |
| Am J Pathol. 2003 Nov; 163(5): 1997–2008. |
| Front Pharmacol. 2017 May 23; 8:269. |
| Front Pharmacol. 2017; 8:20. |
| Behav Pharmacol. 2017 Apr;28(2-3):142-160. |
| New York Times. Oct 27, 2018. |
| Chem Biodivers. 2007 Aug;4(8):1729-43. |
| J Psychopharmacol. 2013 Mar;27(3):312-6. |
| J Clin Pharmacol. 1981 Aug-Sep;21(S1):417S-427S. |
| Curr Neuropharmacol. 2014 May; 12(3): 269–272. |
| Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1191-9. |
| Pain. 2017 Dec;158(12):2442-2451. |
| Journal of Neuroendocrinology 20 (Suppl. 1), 10–14 |
| Int J Mol Sci. 2018 Mar; 19(3): 833. |
| The Scientist. July/Aug 2017. |
| ClinicalTrials.gov |
| Br J Pharmacol. 2011 Aug; 163(7): 1344–1364. |
| JAMA. 2017;318(17):1708-1709. |
